Chicago, IL (PRWEB) January 10, 2017
Billions of dollars have recently flowed into Anti-Aging Medical research and Regenerative Medicine, from the likes of Silicon Valley & Biotech Startups chasing after the 'Fountain of Youth', such as Calico (Google), Johnson & Johnson, Human Longevity Inc, Elysium Health, Synthetic Genomics, GlaxoSmithKline / Sinclair, Startup Health, Mayo Clinic, Scripps Research, Roche , Novartis (Rapamycin), AstraZeneca, AbbVie, Pfizer, Sanofi, Medtronic/Covidien, IBM Watson Healthcare, Quest, Apple, Microsoft, Qualcomm, Facebook, Amazon, Novo Nordisk and other giants.
The FDA finally recognized 'Aging' as a possible disorder that the medical community could target and potentially treat. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471741/). This is a stance the American Academy of Ant-Aging Medicine (A4M) (http://www.Worldhealth.net, http://www.A4M.com) has been stating for decades, notes A4M President Dr. Ronald Klatz. "'Aging is Not Inevitable' and we are seeing the largest paradigm shift in the history of medicine. There are many ways medicine, nutrition, and exercise can slow down, halt, or even reverse the effects of aging on our bodies. Much of the medical community is starting to recognize this.” The American Academy of Anti-aging Medicine has over 26,000 medical professionals in over 120 countries that now lead the thought process as to how to approach medicine. “Just look how after almost 3 Decades of Healthcare Leadership all the big players are starting to move into the Anti-aging, Regenerative and Preventative medicine space," explains Dr. Ronald Klatz.
At CES here in Las Vegas, hundreds of companies are addressing health and healthcare related issues from wearables to diagnostics. It's exciting! Read more about these exciting Future of Medicine Predictions at: https://www.facebook.com/1214703941/posts/10211585463611566/ or http://www.worldhealth.net/news/future-predictions-2017-2045/